Strategic Focus Transit Scientific is a development stage medical device company with FDA and CE clearance for its XO Score and XO Cross platforms, presenting clear upsell and cross-sell opportunities to cardiovascular and vascular interventional supply chains and distribution partners.

Clinical Adoption Recent press coverage highlights early clinical use and multi-site launches for XO Cross microcatheters and scoring sheath, indicating growing clinician familiarity and potential demand growth in interventional suites.

Product Advantage The XO Score scoring sheath and XO Cross microcatheters offer unique capabilities to convert standard balloons and enhance vessel prep, pushability, trackability and cost-effectiveness, presenting a compelling value proposition to hospitals seeking updated device baskets.

Market Positioning With multiple regulatory clearances and international expansion plans, there is an opportunity to partner with distributors and regional medical device groups to accelerate adoption in key markets and complement existing interventional device portfolios.

Funding and Growth Revenue is currently under one million, suggesting a need for strategic partnerships, co-marketing, and bundled purchasing programs with larger device manufacturers or distributors to scale sales and reach targeted accounts.